Fitness Trackers and Diabetes: How to Choose Useful Features
Fitness trackers can support activity goals, but they are not a diabetes medical device for...
First CKM Guideline: What Diabetes Patients Should Know
A new AHA/ACC/ADA/ASN guideline connects diabetes, kidney, weight and heart risk. Here is what patients...
Fenofibrate and Diabetic Retinopathy: What a New Meta-Analysis Found
A new meta-analysis suggests fenofibrate may slow established diabetic retinopathy, but it did not clearly...
FDA Weight-Loss Supplement Warnings: Toxic Yellow Oleander and Hidden Sibutramine
FDA testing found toxic yellow oleander in several products marketed for weight loss and undeclared...
FDA Clears OTC CGM for Children: What Families Should Know
FDA cleared Dexcom Stelo as the first over-the-counter CGM for children age 2 and older...
FDA Authorizes Libre Duo: Continuous Glucose and Ketone Monitoring Explained
The FDA has authorized Libre Duo 10 Day for people aged 2 and older with...
Fatty Liver Disease and Diabetes: Heart Risk to Watch
Plain-language guide to fatty liver disease, diabetes, and cardiovascular risk, with screening questions, safety notes...
Family-Focused Support for Young People With Type 1 Diabetes: What a New Meta-Analysis Found
A meta-analysis of 62 randomized trials found modest HbA1c benefits from behavioral support, with stronger...
Evolocumab and Cardiovascular Risk in High-Risk Diabetes: What VESALIUS-CV Found
A prespecified VESALIUS-CV analysis found fewer major cardiovascular events with evolocumab in selected adults with...